Cellular therapy in the Asia-Pacific region. A guide for the future pathologist

The Asia-Pacific region includes a large number of countries offering a broad range and quality of healthcare services. Almost every country in the region offers at least some cellular therapies, from the highly regulated countries like Japan, Korea and Australia, through to countries where the over...

Full description

Saved in:
Bibliographic Details
Published in:Pathology 2011-10, Vol.43 (6), p.616-626
Main Authors: Macpherson, Janet L., Rasko, John E.J.
Format: Article
Language:English
Subjects:
Aged
Animals
Asia
Australasia
Cell therapy
Cell Transplantation - trends
Disease Models, Animal
Humans
Pathology - trends
Precision Medicine
regenerative medicine
stem cell transplantation
Tissue and Organ Procurement - statistics & numerical data
tissue engineering
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The Asia-Pacific region includes a large number of countries offering a broad range and quality of healthcare services. Almost every country in the region offers at least some cellular therapies, from the highly regulated countries like Japan, Korea and Australia, through to countries where the oversight is less formal. The key healthcare drivers for this sector are the ageing population, obesity epidemic, organ donation statistics and the emergence of personalised medicine. This is a rapidly advancing field with breakthroughs announced regularly. The Asia-Pacific region is poised to become a world leader in the provision of this new generation of therapeutic options in a safe and standardised manner.
ISSN:0031-3025
1465-3931
DOI:10.1097/PAT.0b013e32834ac48e